|
Home:
PCU 3 2002: CME Audio Series and Activity
Prostate Cancer Update: A CME Audio Series and Activity
Statement of need /Target audience
Prostate cancer is one of the most rapidly evolving fields in
urology. Published results from clinical trials lead to the emergence
of new surgical and radiation therapy techniques as well as therapeutic
agents, along with changes in the indications for existing treatments.
In order to offer optimal patient care — including the option
of clinical trial participation — the practicing urologist
must be well-informed of these advances.
To bridge the gap between research and patient care, Prostate
Cancer Update utilizes one-on-one discussions with leading urologic
oncology investigators. By providing access to the latest research
developments and expert perspectives, this CME program assists physicians
in the formulation of up-to-date clinical management strategies.
Issue 3, 2002 of Prostate Cancer Update consists of discussions
with four research leaders about several patient management scenarios
and a variety of important topics including selecting local therapy
for younger patients, therapeutic options for patients with intermediate-risk
prostate cancer, the clinical utility of postoperative nomograms,
ongoing prostate cancer prevention clinical trials and bicalutamide
as immediate therapy either alone or as adjuvant to standard care
of patients with localized or locally advanced prostate cancer.
Educational objectives
Upon completion of this activity, participants should be able
to:
- Distinguish patients with prostate cancer for whom radiation
plus hormonal therapy is
appropriate.
- Evaluate issues regarding the timing and selection of hormonal
therapy for prostate
cancer patients who have undergone definitive local therapy.
- Differentiate the risks and benefits of hormonal therapies
including antiandrogen
therapy and medical or surgical castration.
- Identify patient perspectives in therapy decision-making in
order to more effectively
counsel patients about the risks and benefits of various therapy
choices available to them.
- Understand the impact of biochemical failure on patients in
order to assist them in
making decisions about available therapeutic options.
- Understand the clinical utility of using postoperative nomograms
in order to counsel
patients about the potential value of adjuvant therapy.
Accreditation statement
This activity has been planned and implemented in accordance with
the Essential Areas and Policies of the Accreditation Council for
Continuing Medical Education (ACCME) through the joint sponsorship
of the Postgraduate Institute for Medicine and NL Communications,
Inc. The Postgraduate Institute for Medicine is accredited by the
ACCME to provide continuing medical education for physicians.
Designation statement
The Postgraduate Institute for Medicine designates this educational
activity for a maximum of 3 hours in category 1 credit toward the
A M A Physician's Recognition Award. Each physician should claim
only those hours of credit that he/she actually spent in the activity.
Faculty disclosure statements
The Postgraduate Institute for Medicine has a conflict of interest
policy that requires course faculty to disclose any real or apparent
commercial financial affiliations related to the content of their
presentations/materials. It is not assumed that these financial
interests or affiliations will have an adverse impact on faculty
presentations; they are simply noted in this supplement to fully
inform participants.
|
